Milla Pharmaceuticals
Drug Stores & Pharmacies · Minnesota, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
601 Carlson Pkwy Ste 1050, Minnetonka, M...Phone Number
(302) 482-4584Website
www.millapharmaceuticals.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Milla Pharmaceuticals
Milla Pharmaceuticals, a U.S. subsidiary of A.forall, focuses on the commercialization of high-quality FDA-approved injectable products throughout the United States. The company aims to make affordable medicines accessible to all by leveraging an extensive distribution network that includes wholesalers, hospitals, and infusion care clinics. Headquartered in Belgium, Milla Pharmaceuticals also distributes a wide range of pharmaceutical products to pharmacies and retirement homes. They are open to various partnership arrangements, including commercialization of institutional products and licensing.Explore more
Milla Pharmaceuticals Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Milla Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Milla Pharmaceuticals is spiking on competitors!
Check if Milla Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Milla Pharmaceuticals has new funding data
Click to see if Milla Pharmaceuticals had a recent Job posting/layoffs
Earning: See what the market has to say on Milla Pharmaceuticals recently announced quarterly report
Milla Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Milla Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Milla Pharmaceuticals launches new products
Recommended Actions
Find VP level buyers at Milla Pharmaceuticals
Find 3 more new buyers
Compare Similar Companies to Milla Pharmaceuticals
Compare insights from companies similar to Milla Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Milla Pharmaceuticals is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
Milla Pharmaceuticals is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about Milla Pharmaceuticals.
Milla Pharmaceuticals Tech Stack
A closer look at the technologies used by Milla Pharmaceuticals
See more technologies
Milla Pharmaceuticals News & Media
A.forall Announces the Launch of Their Fifth Abbreviated New Drug Application (ANDA) and Second “First Cycle” FDA Approval
MINNETONKA, Minn.--(BUSINESS WIRE)--A.forall’s U.S. subsidiary Milla Pharmaceuticals Inc. announced the launch of the group’s generic version of Precedex®, Dexmedetomidine Hydrochloride Injection 200 mcg per 50 mL and 400 mcg per 100 mL in 0.9% sodium chloride in glass bottles by its partner Sagent Pharmaceuticals. Dexmedetomidine Hydrochloride Injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. DexmedetoA.forall Announces Launch of a Generic Version of Sodium Acetate Injection 4 mEq/mL
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., an A.forall company, announced that its partner, Woodward Pharma Services LLC, has just commercialized its Supplemental Abbreviated New Drug Application (sANDA) approval from the U.S. Food and Drug Administration (FDA) for a generic version of Sodium Acetate Injection 4 mEq/mL marketed by Fresenius Kabi USA LLC. Sodium Acetate Injection 4 mEq/mL is indicated as a source of sodium for addition to large volume intravenous fluids to pA.forall Announces Launch of a Generic Version of Pyridostigmine Bromide Syrup
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., an A.forall company, announced that its partner, Acella Pharmaceuticals LLC, has just commercialized its Abbreviated New Drug Application (ANDA) approval from the U.S. Food and Drug Administration (FDA) for a generic version of Mestinon® (Pyridostigmine Bromide Syrup) 60 mg/5mL. Pyridostigmine Bromide Syrup is indicated for symptomatic treatment of myasthenia gravis. Myasthenia gravis is a neuromuscular disorder primarily characterMilla Pharmaceuticals Inc. and the Alter Pharma Group Announce Yet Another “First Cycle” FDA Approval for an Abbreviated New Drug Application (ANDA), Dexmedetomidine Hydrochloride Injection
MINNETONKA, Minn.--(BUSINESS WIRE)--Milla Pharmaceuticals Inc., a subsidiary of the Alter Pharma Group, announced that it has received FDA approval for its generic version of Precedex®, Dexmedetomidine Hydrochloride Injection 4mcg/ml in 50mL and 100mL, and plans to launch in the very near future. Dexmedetomidine Hydrochloride Injection is indicated for sedation of initially intubated and mechanically ventilated patients during treatment in an intensive care setting. It should be administered by
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Milla Pharmaceuticals
Sign Up For FreeTo access detailed company insights
Milla Pharmaceuticals, a U.S. subsidiary of A.forall, focuses on the commercialization of high-quality FDA-approved injectable products throughout the United States. The company aims to make affordable medicines accessible to all by leveraging an extensive distribution network that includes wholesalers, hospitals, and infusion care clinics. Headqua... Read More
